<DOC>
	<DOCNO>NCT00000223</DOCNO>
	<brief_summary>The purpose study determine three time subject 's daily maintenance dose hold 72 hour without change agonist antagonist effect .</brief_summary>
	<brief_title>Alternate-Day Buprenorphine Administration . Phase IV - 5</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 1994</verification_date>
</DOC>